In recent years, smartwatches and smart rings have grown increasingly popular, adorning the wrists and fingers of consumers ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Devices like the Lingo and the Stelo work exactly like a diabetic glucose monitor, although some experts doubt their value ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

More than 10 years ago, Abbott introduced FreeStyle Libre — a continuous glucose monitor now used by 6 million people ...

Apple tests app to help prediabetes management, hinting at competition with glucose monitoring leaders Abbott and DexCom.

Abbott (NYSE: ABT) recently reported its Q3 results, with revenues and earnings slightly above our expectations.

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the U.S., expanding ...

Apple (AAPL) tests an app for prediabetes management posing a competitive threat to makers of CGM devices such as DexCom ...

Comcast debacle could diminish interest in Bulls and Blackhawks Will glucose monitors become the next wellness accessory?